Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause Rectal haemorrhage? 121 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Rectal haemorrhage have been filed in association with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. This represents 68.8% of all adverse event reports for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS.
121
Reports of Rectal haemorrhage with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
68.8%
of all BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS reports
0
Deaths
88
Hospitalizations
How Dangerous Is Rectal haemorrhage From BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS?
Of the 121 reports, 88 (72.7%) required hospitalization.
Is Rectal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. However, 121 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause?
Nausea (139)
Anaemia (132)
Headache (132)
Pyrexia (132)
Constipation (128)
Pain (128)
Erythema (127)
Female genital tract fistula (127)
Oral candidiasis (126)
Proctitis (126)
What Other Drugs Cause Rectal haemorrhage?
RIVAROXABAN (4,501)
ASPIRIN (3,057)
ADALIMUMAB (2,629)
VEDOLIZUMAB (2,163)
INFLIXIMAB (1,554)
CLOPIDOGREL BISULFATE (1,333)
APIXABAN (1,177)
WARFARIN (1,174)
PREDNISONE (1,098)
MESALAMINE (990)
Which BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Alternatives Have Lower Rectal haemorrhage Risk?
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BILASTINE
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB-BKZX